These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31699200)

  • 1. [Advances in Autoantibodies against C-reactive Protein in Systemic Lupus Erythematosus].
    Li QY; Yu F
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):678-684. PubMed ID: 31699200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
    Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
    Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CRP autoantibody levels correlate with disease activity in systemic lupus erythematosus.
    Sjöwall C; Bengtsson AA; Sturfelt G; Skogh T
    Semin Arthritis Rheum; 2005 Aug; 35(1):65; author reply 66. PubMed ID: 16084226
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions.
    Tan Y; Yu F; Yang H; Chen M; Fang Q; Zhao MH
    Hum Immunol; 2008 Dec; 69(12):840-4. PubMed ID: 18852001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
    Brilland B; Vinatier E; Subra JF; Jeannin P; Augusto JF; Delneste Y
    Front Immunol; 2020; 11():626343. PubMed ID: 33664737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential clearance mechanisms, neutrophil extracellular trap degradation and phagocytosis, are operative in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Rai R; Singh VV; Rai M; Rai G
    Immunol Lett; 2015 Dec; 168(2):254-9. PubMed ID: 26434792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
    Yuan M; Tan Y; Pang Y; Li YZ; Song Y; Yu F; Zhao MH
    Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.
    Yang XW; Tan Y; Yu F; Zhao MH
    Hum Immunol; 2012 Feb; 73(2):156-63. PubMed ID: 22192784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular vesicles opsonized by monomeric C-reactive protein (CRP) are accessible as autoantigens in patients with systemic lupus erythematosus and associate with autoantibodies against CRP.
    Karlsson J; Wetterö J; Potempa LA; Fernandez-Botran R; O'Neill Y; Wirestam L; Mobarrez F; Sjöwall C
    J Autoimmun; 2023 Sep; 139():103073. PubMed ID: 37356347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to apolipoprotein A-I, high-density lipoprotein, and C-reactive protein are associated with disease activity in patients with systemic lupus erythematosus.
    O'Neill SG; Giles I; Lambrianides A; Manson J; D'Cruz D; Schrieber L; March LM; Latchman DS; Isenberg DA; Rahman A
    Arthritis Rheum; 2010 Mar; 62(3):845-54. PubMed ID: 20131231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoimmune reactivity to malondialdehyde adducts in systemic lupus erythematosus is associated with disease activity and nephritis.
    Hardt U; Larsson A; Gunnarsson I; Clancy RM; Petri M; Buyon JP; Silverman GJ; Svenungsson E; Grönwall C
    Arthritis Res Ther; 2018 Feb; 20(1):36. PubMed ID: 29482604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients.
    Sherer Y; Gorstein A; Fritzler MJ; Shoenfeld Y
    Semin Arthritis Rheum; 2004 Oct; 34(2):501-37. PubMed ID: 15505768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
    Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH
    J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pentraxins - their importance in pathogenesis of systemic lupus erythematosus].
    Jakuszko K; Krajewska M; Weyde W; Grzegorczyk K; Klinger M
    Postepy Hig Med Dosw (Online); 2011 Sep; 65():597-605. PubMed ID: 21918264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
    Holers VM
    J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CRP antibodies in systemic lupus erythematosus.
    Meyer O
    Joint Bone Spine; 2010 Oct; 77(5):384-9. PubMed ID: 20627790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A volcanic explosion of autoantibodies in systemic lupus erythematosus: a diversity of 180 different antibodies found in SLE patients.
    Yaniv G; Twig G; Shor DB; Furer A; Sherer Y; Mozes O; Komisar O; Slonimsky E; Klang E; Lotan E; Welt M; Marai I; Shina A; Amital H; Shoenfeld Y
    Autoimmun Rev; 2015 Jan; 14(1):75-9. PubMed ID: 25449682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical utility of anti-ribosomal P autoantibodies in systemic lupus erythematosus.
    Pasoto SG; Viana VS; Bonfa E
    Expert Rev Clin Immunol; 2014 Nov; 10(11):1493-503. PubMed ID: 25292164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR4
    Ma K; Li J; Wang X; Lin X; Du W; Yang X; Mou F; Fang Y; Zhao Y; Hong X; Chan KW; Zhang X; Liu D; Sun L; Lu L
    Ann Rheum Dis; 2018 Oct; 77(10):1498-1506. PubMed ID: 29925508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.